Jo‐anne E Brien

2.9k total citations · 1 hit paper
97 papers, 2.0k citations indexed

About

Jo‐anne E Brien is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Jo‐anne E Brien has authored 97 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Geriatrics and Gerontology, 26 papers in Economics and Econometrics and 25 papers in General Health Professions. Recurrent topics in Jo‐anne E Brien's work include Pharmaceutical Practices and Patient Outcomes (51 papers), Patient Safety and Medication Errors (22 papers) and Health Systems, Economic Evaluations, Quality of Life (20 papers). Jo‐anne E Brien is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (51 papers), Patient Safety and Medication Errors (22 papers) and Health Systems, Economic Evaluations, Quality of Life (20 papers). Jo‐anne E Brien collaborates with scholars based in Australia, United States and Ethiopia. Jo‐anne E Brien's co-authors include Andrew J. McLachlan, Alemayehu Mekonnen, Parisa Aslani, Sujata Sapkota, Stephen Jan, Jerry R. Greenfield, Tracey‐Lea Laba, Gisselle Gallego, Susan Taylor and Elin C. Lehnbom and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jo‐anne E Brien

90 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis

2016 340 citations Alemayehu Mekonnen, Andrew J. McLachlan et al. BMJ Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jo‐anne E Brien Australia	23	1.0k	503	442	394	388	97	2.0k
Leslie Fish United States	13	1.2k 1.1×	416 0.8×	356 0.8×	414 1.1×	228 0.6×	16	1.9k
Benoît Allenet France	26	1.2k 1.2×	457 0.9×	453 1.0×	282 0.7×	270 0.7×	119	2.1k
Divaldo Pereira de Lyra Brazil	27	1.2k 1.1×	298 0.6×	514 1.2×	260 0.7×	508 1.3×	161	2.2k
Daniel R. Touchette United States	24	785 0.8×	194 0.4×	361 0.8×	422 1.1×	331 0.9×	94	1.8k
Joshua Borus United States	9	864 0.8×	496 1.0×	290 0.7×	163 0.4×	270 0.7×	19	1.7k
Kurt E. Hersberger Switzerland	27	1.7k 1.6×	294 0.6×	967 2.2×	539 1.4×	386 1.0×	138	2.9k
J. Ross Maclean United States	15	1.4k 1.4×	197 0.4×	395 0.9×	816 2.1×	360 0.9×	29	2.7k
Kirsten K. Viktil Norway	20	1.2k 1.2×	368 0.7×	336 0.8×	325 0.8×	130 0.3×	37	1.7k
Michelle A. Chui United States	25	756 0.7×	332 0.7×	302 0.7×	167 0.4×	412 1.1×	102	1.6k
Christian Swine Belgium	16	1.4k 1.4×	210 0.4×	320 0.7×	682 1.7×	325 0.8×	44	2.0k

Countries citing papers authored by Jo‐anne E Brien

Since Specialization

Citations

This map shows the geographic impact of Jo‐anne E Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo‐anne E Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo‐anne E Brien more than expected).

Fields of papers citing papers by Jo‐anne E Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo‐anne E Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo‐anne E Brien. The network helps show where Jo‐anne E Brien may publish in the future.

Co-authorship network of co-authors of Jo‐anne E Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Jo‐anne E Brien. A scholar is included among the top collaborators of Jo‐anne E Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo‐anne E Brien. Jo‐anne E Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laba, Tracey‐Lea, Thomas Lung, Stephen Jan, et al.. (2018). Medication non-adherence in a cohort of chronically ill Australians: A case of missed opportunities.. PubMed. 47(8). 556–562. 5 indexed citations

Sapkota, Sujata, Jo‐anne E Brien, Josephine Gwynn, Victoria Flood, & Parisa Aslani. (2017). Perceived impact of Nepalese food and food culture in diabetes. Appetite. 113. 376–386. 16 indexed citations

Mekonnen, Alemayehu, et al.. (2016). Medication reconciliation as a medication safety initiative in Ethiopia: a study protocol. BMJ Open. 6(11). e012322–e012322. 11 indexed citations

Aslani, Parisa, Sujata Sapkota, & Jo‐anne E Brien. (2016). Nepalese patients’ perceptions of treatment modalities for type 2 diabetes. Patient Preference and Adherence. Volume 10. 1777–1786. 19 indexed citations

Mekonnen, Alemayehu, Andrew J. McLachlan, & Jo‐anne E Brien. (2016). Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 6(2). e010003–e010003. 340 indexed citations breakdown →

Sapkota, Sujata, Jo‐anne E Brien, Jerry R. Greenfield, & Parisa Aslani. (2015). A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes—Components of Interventions. PLoS ONE. 10(6). e0128581–e0128581. 54 indexed citations

Sinha, Yashwant, Jonathan C. Craig, Peter Barclay, et al.. (2014). A national study of the processes and outcomes of paediatric formulary applications in Australia. The Medical Journal of Australia. 200(9). 541–545. 3 indexed citations

Laba, Tracey‐Lea, Jo‐anne E Brien, Marlene Fransen, & Stephen Jan. (2013). Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS). BMC Musculoskeletal Disorders. 14(1). 160–160. 74 indexed citations

Laba, Tracey‐Lea, Jo‐anne E Brien, & Stephen Jan. (2012). Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia. BMC Family Practice. 13(1). 61–61. 24 indexed citations

10.

Hall, Wayne, Robyn L. Ward, Winston Liauw, Jo‐anne E Brien, & Christine Y. Lu. (2005). Tailoring access to high cost, genetically targeted drugs. The Medical Journal of Australia. 182(12). 607–608. 12 indexed citations

11.

Welch, Susan, et al.. (2004). Omitted Medication Doses: Frequency and Severity. Journal of Pharmacy Practice and Research. 34(3). 174–177. 20 indexed citations

12.

Maxwell, David, et al.. (2004). Evaluation of Mycophenolate for Unregistered Indications. Journal of Pharmacy Practice and Research. 34(1). 36–38. 1 indexed citations

13.

Brien, Jo‐anne E, et al.. (2004). Pharmacist Prescribing: Review of the Literature. Journal of Pharmacy Practice and Research. 34(4). 300–304. 18 indexed citations

14.

Brien, Jo‐anne E, et al.. (2004). Pharmacist Prescribing—Lessons from Abroad. Journal of Pharmacy Practice and Research. 34(4). 259–261. 2 indexed citations

15.

Day, Richard O., et al.. (2004). Stakeholder Opinions on the Implementation of Drug and Therapeutics Committee Decisions. Journal of Pharmacy Practice and Research. 34(3). 178–182. 3 indexed citations

16.

Gallego, Gisselle, et al.. (2004). Impact of High‐Cost Drugs for Individual Patient Use. Journal of Pharmacy Practice and Research. 34(2). 100–103. 5 indexed citations

17.

Day, Richard O., et al.. (2003). Improving Decision Outcomes of Drug and Therapeutics Committees. Journal of Pharmacy Practice and Research. 33(1). 65–67. 4 indexed citations

18.

Brien, Jo‐anne E. (2003). Pharmacogenomics—Clinical and Social Implications. Journal of Pharmacy Practice and Research. 33(3). 224–227. 1 indexed citations

19.

McLennan, Danielle N, Michael Dooley, & Jo‐anne E Brien. (1999). ICD‐10‐AM Activity Codes: An Opportunity for Standardisation. The Australian Journal of Hospital Pharmacy. 29(5). 261–264. 7 indexed citations

20.

Brien, Jo‐anne E & David A. Ford. (1999). A New Course in Clinical Pharmacy in Victoria. The Australian Journal of Hospital Pharmacy. 29(2). 95–99.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact